Technology | August 29, 2006

Varian Medical Systems Inc. has received FDA clearance that permits the use of the company’s Trilogy linear accelerators on an expanded range of medical conditions. The clearance also marks the introduction of Varian’s new Trilogy Tx Image-Guided Radiosurgery (IGRS) model designed specifically for surgeons.
The Trilogy and Trilogy Tx machines now can be used for stereotactic radiosurgery as well as precision radiotherapy for lesions, tumors and conditions anywhere in the body when radiation treatment is indicated.


Related Content

News | Proton Therapy

January 26, 2024 — P-Cure continues its quest to successfully usher in a new era of clinical treatment with proton ...

Time January 26, 2024
arrow
News | Linear Accelerators

October 25, 2023 — A new order for several Elekta Harmony linear accelerators (linacs) in Ukraine will complement the ...

Time October 25, 2023
arrow
News | Radiation Therapy

October 5, 2023 — A new study, led by radiation oncology physicists at Miami Cancer Institute, part of Baptist Health ...

Time October 05, 2023
arrow
News | Oncology Information Management Systems (OIMS)

May 24, 2023 — RaySearch Laboratories AB announced that the oncology information system RayCare* (* subject to ...

Time May 24, 2023
arrow
News | Proton Therapy

April 3, 2023 — P-Cure announced clearance of its Adaptive Proton Therapy Solution by the FDA for sales in the USA. P ...

Time April 03, 2023
arrow
News | Radiation Therapy

February 28, 2023 — Elekta announced that Comprehensive Motion Management (CMM) with True Tracking and automatic gating ...

Time February 28, 2023
arrow
News | Radiation Therapy

February 6, 2023 — Varian, a Siemens Healthineers company, announced that it has received 510(k) clearance from the U.S ...

Time February 06, 2023
arrow
News | Proton Therapy

January 13, 2023 — RaySearch Laboratories AB announces that The Ohio State University Comprehensive Cancer Center - ...

Time January 13, 2023
arrow
News | Linear Accelerators

December 30, 2022 — A milestone was reached in radiation therapy last week as the first patients completed their full ...

Time December 30, 2022
arrow
News | Quality Assurance (QA)

May 3, 2022 — Sun Nuclear Corporation, a wholly-owned subsidiary of Mirion Technologies, Inc., today announced the ...

Time May 03, 2022
arrow
Subscribe Now